BioNTech SE
Jim Cramer’s week ahead: Get ready to ‘pounce’ when the market is oversold
CNBC’s Jim Cramer on Friday warned investors not to let their guard down when it comes to their portfolios and be ready to take advantage of good deals. “Ultimately, you’re just going to feel sorry if you don’t buy anything on the big sell-offs. When the market finally gets oversold enough, though, that’s when you […]
Read More
New hope China may soften on Covid boosts our stocks most tied to world’s No. 2 economy
Estee Lauder (EL) and other Club holdings with meaningful exposure to the Chinese economy bounced Friday, following news that BioNTech ‘s (BNTX) Covid vaccine will soon be available to foreign residents living in China. We’re cautiously optimistic about the vaccine development , which adds to hopes that Beijing will soften its restrictive pandemic policies after […]
Read More
Omicron BA.5 is declining in the U.S. as emerging variants gain ground, CDC data shows
The U.S. faces at least seven different versions of Covid-19 omicron as the nation heads into winter when health officials are expecting another wave of viral infections. Although the omicron BA.5 variant remains dominant in the country, it is starting to lose some ground to other versions of the virus, according to data from the […]
Read More
Pfizer says omicron shots substantially boosted antibodies against BA.5 subvariant in early human data
Jakub Porzycki | NurPhoto | Getty Images Pfizer and its German partner BioNTech on Thursday said their new omicron boosters substantially increased protective antibodies against the dominant omicron BA.5 subvariant for adults in the first direct human data released to the public on the new shots. The study looked at blood samples taken from 40 […]
Read More
A series of mega-blockbuster drugs are on the horizon. How to invest in the trend
Biopharma companies are having more clinical success treating Alzheimer’s disease and obesity and are taking new approaches in oncology, and that’s creating more mega-blockbuster drugs, according to Bank of America. Analyst Geoff Meacham has identified 20 drugs that have the potential to generate $10 billion or more in annual sales by 2030 within the universe […]
Read More
Covid vaccination linked to slight increase in menstrual cycle, NIH study confirms
A healthcare worker administers a dose of the Pfizer-BioNTech Covid-19 vaccine at a vaccination clinic in the Peabody Institute Library in Peabody, Massachusetts, U.S., on Wednesday, Jan. 26, 2022. Vanessa Leroy | Bloomberg | Getty Images Covid-19 vaccination is linked to a slight increase in the length of a women’s menstrual cycle, delaying the beginning […]
Read More
Stocks producing the most significant moves midday: Change Health care, Ford, PayPal, Humana and more
In this posting GM F LVS NVAX MRNA BNTX Ford Motor Firm’s electric F-150 Lightning on the manufacturing line at their Rouge Electric Motor vehicle Centre in Dearborn, Michigan on September 8, 2022. Jeff Kowalsky | AFP | Getty Images Test out the organizations creating headlines in midday investing Tuesday. Transform Healthcare – Shares of […]
Read More
Stocks making the largest moves in the premarket: Ford, Improve Health care, Cognex and more
observe now Video:5200:52 Wall Avenue set to open up in the purple as Fed kicks off September conference Early morning Report Get a look at some of the major movers in the premarket: Ford (F) – The automaker’s stock fell 4.5% in the premarket right after it warned that quarterly earnings would acquire a hit […]
Read More
Deutsche Bank upgrades Moderna, says strong second-quarter results set up the stock for big gain ahead
Strong second-quarter results from Moderna make now an opportune time to buy shares of the biotechnology company, Deutsche Bank said. Analyst Emmanuel Papadakis upgraded shares of the Covid-19 vaccine maker to buy, citing quarterly numbers that beat analyst expectations . Papadakis also pointed to additional contracts unaccounted for in the company’s previous guidance and a […]
Read More
Omicron boosters are a key milestone, but aren’t likely to woo new investors to Pfizer, Moderna
It’s a new milestone in the Covid-19 pandemic. People will soon roll up their sleeves and get jabbed with a booster shot tailored to the dominant coronavirus strain circulating in the U.S. Health officials have suggested this is likely to become a new pattern, joining the annual ritual of the flu shot. “For the first […]
Read More